secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K/A
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001628280-25-037425
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Indivior assigns new director Kingsley to Audit & Risk and Compensation committees
--------------------------------------------------------------------------------

- Stuart A. (Tony) Kingsley appointed non-executive director effective July 1, 2025.
- He will serve on the Audit & Risk Committee and the Compensation Committee.
- Appointment previously disclosed; amendment adds committee assignment details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162828025037425/0001628280-25-037425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162828025037425/indv-20250620.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-037425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer